Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$82,216,583
+$12,565,578 QoQ
Shares Held
3,414,310
+37.6% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#114
of 2,834 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2024CallValue
$12
CallShares
20
PutValue
$46
PutShares
40
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Federation des caisses Desjardins du Quebec holds $784,151,867 across 18 Drug Manufacturers - General names. PFE ranks #3 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,035,263 | $262,925,742 | |
| 2 | LLY |
ELI LILLY & Co
|
135,322 | $162,309,278 | |
| 3 | PFE |
Pfizer Inc
This page
|
3,414,310 | $82,216,583 | |
| 4 | MRK |
Merck & Co., Inc.
|
514,231 | $66,078,682 | |
| 5 | ABBV |
AbbVie Inc.
|
212,267 | $53,414,866 | |
| 6 | AZN |
Astrazeneca PLC
|
209,951 | $39,810,907 | |
| 7 | SNY |
Sanofi
|
873,273 | $37,253,825 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
214,642 | $27,117,868 |
All Filings in PFE
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,216,583 | 3,414,310 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $69,651,005 | 2,480,449 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $58,242,070 | 2,339,039 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $59,187,720 | 2,322,909 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $51,962,316 | 2,143,660 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $53,077,010 | 2,094,594 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $39,308,278 | 1,481,654 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $62,130,416 | 2,146,870 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $46 | 40 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $50,270,210 | 1,796,648 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $12 | 20 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $49,333,755 | 1,777,793 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $34,075,181 | 1,183,577 | Shares | Defined | 2024-08-15 | |
| 2023-09-30 | $39,319,850 | 1,185,404 | Shares | Defined | 2024-08-15 | |
| 2023-06-30 | $37,337,341 | 1,017,921 | Shares | Defined | 2024-08-15 | |
| 2023-03-31 | $37,827,923 | 927,155 | Shares | Defined | 2024-08-15 | |
| 2022-12-31 | $47,669,391 | 930,316 | Shares | Defined | 2024-08-15 | |
| 2022-09-30 | $40,996,555 | 936,850 | Shares | Defined | 2024-08-15 | |
| 2022-06-30 | $50,015,964 | 953,957 | Shares | Defined | 2024-08-15 | |
| 2022-03-31 | $48,405,518 | 935,011 | Shares | Defined | 2024-08-15 | |
| 2021-12-31 | $54,940,060 | 930,399 | Shares | Defined | 2024-08-30 | |
| 2021-09-30 | $39,810,743 | 925,616 | Shares | Defined | 2024-08-30 | |
| 2021-06-30 | $43,256,800 | 1,104,617 | Shares | Defined | 2024-08-30 | |
| 2021-03-31 | $29,974,781 | 827,347 | Shares | Defined | 2024-08-30 | |
| 2020-12-31 | $27,903,488 | 758,041 | Shares | Defined | 2024-08-30 | |
| 2020-09-30 | $21,619,141 | 589,078 | Shares | Defined | 2024-08-30 | |
| 2020-06-30 | $20,998,097 | 642,143 | Shares | Defined | 2024-08-30 | |
| 2020-03-31 | $19,191,477 | 587,975 | Shares | Defined | 2024-08-30 | |
| No filing history on record for this holder in this stock. | ||||||